Expression and clinical significance of stem cell marker Lgr5 protein in human gastric carcinoma

doi:10.3877/cma.j.issn.1674-0793.2016.06.005

Abstract

Abstract:

Objective

To investigate the expression and its significance of Lgr5 protein in gastric cancer.

Methods

Lgr5 expression was detected by immunohistochemistry in normal tissues, paracancerous tissues and gastric cancer tissues of 70 patients with gastric cancer treated from January 2012 to June 2015. Clinicopathological information and prognosis data of these 70 patients were analyzed to figure out the role of Lgr5 in gastric cancer.

Results

The expression rate of Lgr5 in tumor tissues (50/70, 71.4%) was significant higher than that in both normal tissues (21/70, 30.0%, χ²=24.034, P=0.000) and paracancerous tissues (35/70, 50.0%, χ²=6.738, P=0.009). Lgr5 expression was significantly correlated with TNM stage and lymph node metastasis. There was no correlation between expression of Lgr5 with age, differentiation, and clinical characteristics in gastric cancer. Kaplan-Meier analysis showed significant difference in 3-year survival rates between groups with and without Lgr5 expression (χ²=3.929, P=0.047).

Conclusions

Expression of Lgr5 in gastric cancer indicates that stem cells may be involved in the pathogenesis of gastric cancer and Lgr5 may play an important role in the development and progression of gastric cancer. Lgr5 expression might be a useful marker of poor prognosis in gastric cancer.

Key words: Stomach neoplasms, Stem cell, Leucine, G-protein-coupled receptor kinase 5

Jianglong Huang, Bo Wei, Zongheng Zheng, Jianpei Liu, Tufeng Chen, Yong Huang, Jiafeng Fang. Expression and clinical significance of stem cell marker Lgr5 protein in human gastric carcinoma[J]. Chinese Archives of General Surgery(Electronic Edition), 2016, 10(06): 406-409.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhptwkxwx.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0793.2016.06.005

https://zhptwkxwx.cma-cmc.com.cn/EN/Y2016/V10/I06/406

Figures/Tables 4

References 17

1	Siegel R,Naishadham D,Jemal A. Cancer statistics, 2013[J]. CA Cancer J Clin, 2013, 63(1): 11-30.
2	Ong BA,Vega KJ,Houchen CW. Intestinal stem cells and the colorectal cancer microenvironment[J]. World J Gastroenterol, 2014, 20(8): 1898-1909.
3	Ribatti D. Cancer stem cells and tumor angiogenesis[J]. Cancer Lett, 2012, 321(1): 13-17.
4	Oliveras-Ferraros C,Vazquez-Martin A,Cuyàs E, et al. Ac-quired resistance to metformin in breast cancer cells triggers tran-scriptome reprogramming toward a degradome-related metastatic stem-like profile[J]. Cell Cycle, 2014, 13(7): 1132-1144.
5	Paldino E,Tesori V,Casalbore P, et al. Tumor initiating cells and chemoresistance: which is the best strategy to target colon cancer stem cells?[J]. Biomed Res Int, 2014, 2014: 859871.
6	Crowder SW,Balikov DA,Hwang YS, et al. Cancer stem cells un-der hypoxia as a chemoresistance factor in breast and brain[J]. Curr Pathobiol Rep, 2014, 2(1): 33-40.
7	Vermeulen L,Morrissey E,van der Heijden M, et al. Defining stem cell dynamics in models of intestinal tumor initiation[J]. Sci-ence, 2013, 342(6161): 995-998.
8	Schmitz V,Barajas M,Wang L, et al. Adenovirus-mediated CD40 ligand gene therapy in a rat model of orthotopic hepatocellular carcinoma[J]. Hepatology, 2001, 34(1): 72-81.
9	Barker N,van Es JH,Kuipers J, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5[J]. Nature, 2007, 449(7165):1003-1007.
10	Barker N,Ridgway RA,van Es JH, et al. Crypt stem cells as the cells-of-origin of intestinal cancer[J]. Nature, 2009, 457(7229): 608-611.
11	Barker N. Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration[J]. Nat Rev Mol Cell Biol, 2014, 15(1): 19-33.
12	Tanese K,Fukuma M,Yamada T, et al. G-protein-coupled recep-tor GPR49 is up-regulated in basal cell carcinoma and promotes cell proliferation and tumor formation[J]. Am J Pathol, 2008, 173(3): 835-843.
13	Becker L,Huang Q,Mashimo H. Immunostaining of Lgr5, an in-testinal stem cell marker, in normal and premalignant human gastrointestinal tissue[J]. ScientificWorldJournal, 2008, 8: 1168-1176.
14	Hartgrink HH,Jansen EP,van Grieken NC, et al. Gastric cancer[J]. Lancet, 2009, 374(9688): 477-490.
15	Yamanoi K,Fukuma M,Uchida H, et al. Overexpression of leu-cine-rich repeat-containing G protein-coupled receptor 5 in gas-tric cancer[J]. Pathol Int, 2013, 63(1): 13-19.
16	Bu Z,Zheng Z,Zhang L, et al. LGR5 is a promising biomarker for patients with stage Ⅰand Ⅱ gastric cancer[J]. Chin J Cancer Res, 2013, 25(1): 79-89.
17	刘元华,樊祥山,恽艳.应用组织芯片技术检测胃癌组织中Lgr5和CD44的表达[J].中国肿瘤外科杂志, 2015, 7(6): 341-345.

组别	n	Lgr5表达				阳性表达率(+~+++,%)
组别	n	-	+	++	+++	阳性表达率(+~+++,%)
胃癌组织	70	20	2	20	28	71.4
癌旁组织	70	35	24	8	3	50.0
正常组织	70	49	14	7	0	30.0
χ²₁,χ²²，χ²³值	?	6.738,24.034,5.833				?
P₁,P₂,P₃值	?	0.009,<0.01,0.016				?

组别	n	Lgr5表达				阳性表达率(+~+++,%)
组别	n	-	+	++	+++	阳性表达率(+~+++,%)
胃癌组织	70	20	2	20	28	71.4
癌旁组织	70	35	24	8	3	50.0
正常组织	70	49	14	7	0	30.0
χ²₁,χ²²，χ²³值	?	6.738,24.034,5.833				?
P₁,P₂,P₃值	?	0.009,<0.01,0.016				?

临床病理特征		例数	Lgr5表达		χ²/t值	P值
临床病理特征		例数	阴性(-)	阳性(+~+++)	χ²/t值	P值
性别		?	?	?	0.358	0.544
?	男	38	12	26	?	?
?	女	32	8	24	?	?
年龄（岁）		?	?	?	0.006	0.939
?	>50	39	11	28	?	?
?	≤ 50	31	9	22	?	?
淋巴结转移		?	?	?	5.606	0.018
?	有	40	7	33	?	?
?	无	30	13	17	?	?
分化程度		?	?	?	3.524	0.060
?	高、中	44	16	28	?	?
?	低	26	4	22	?	?
TNM分期		?	?	?	9.733	0.002
?	Ⅰ、Ⅱ	39	17	22	?	?
?	Ⅲ、Ⅳ	31	3	28	?	?
肿瘤直径(cm)		70	3.575±1.37	3.86±1.229	-0.848	0.399
浸润深度		?	?	?	3.441	0.328
?	T1	10	2	8	?	?
?	T2	19	8	11	?	?
?	T3	30	6	24	?	?
?	T4	11	4	7	?	?
脉管侵犯		?	?	?	0.425	0.514
?	无	58	18	40	?	?
?	有	12	2	10	?	?

临床病理特征		例数	Lgr5表达		χ²/t值	P值
临床病理特征		例数	阴性(-)	阳性(+~+++)	χ²/t值	P值
性别		?	?	?	0.358	0.544
?	男	38	12	26	?	?
?	女	32	8	24	?	?
年龄（岁）		?	?	?	0.006	0.939
?	>50	39	11	28	?	?
?	≤ 50	31	9	22	?	?
淋巴结转移		?	?	?	5.606	0.018
?	有	40	7	33	?	?
?	无	30	13	17	?	?
分化程度		?	?	?	3.524	0.060
?	高、中	44	16	28	?	?
?	低	26	4	22	?	?
TNM分期		?	?	?	9.733	0.002
?	Ⅰ、Ⅱ	39	17	22	?	?
?	Ⅲ、Ⅳ	31	3	28	?	?
肿瘤直径(cm)		70	3.575±1.37	3.86±1.229	-0.848	0.399
浸润深度		?	?	?	3.441	0.328
?	T1	10	2	8	?	?
?	T2	19	8	11	?	?
?	T3	30	6	24	?	?
?	T4	11	4	7	?	?
脉管侵犯		?	?	?	0.425	0.514
?	无	58	18	40	?	?
?	有	12	2	10	?	?

[1]	Yangwenxiang Wei, Haoran Huang, Yuhao Liu, Zhenqiu Chen, Haibin Wang, Chi Zhou. Outlooks and challenges in cell therapy of osteonecrosis of femoral head [J]. Chinese Journal of Joint Surgery(Electronic Edition), 2023, 17(05): 694-700.
[2]	Linian Han, Jun Wang. Advances in the treatment of radiation-induced skin injury [J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2023, 18(06): 533-537.
[3]	Manqing Jia, Jing Bian, Yeping Zhou. Clinical observation of low dose insulin local injection for promotion of adipose derived stem cell transplantation survival and improvement of diabetic wound healing [J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2023, 18(04): 312-316.
[4]	Linfeng He, Yu Cao, Ning Zhang, Xinze Ran, Fengchao Wang. Regulation of intestinal stem cells and tissue damage and repair after radiation exposure [J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2023, 18(04): 358-363.
[5]	Lei Gao, Fang Li, Bayaliga, Quan Li, Te Ba. Progress of immune role of stem cell-derived exosomes in wound repair [J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2023, 18(04): 364-367.
[6]	Bo Mo, Pei Wang, Heng Wang, Zhijun He, Jun Liang, Zhinan Hao. Curative effect of laparoscopic radical gastrectomy and modified radical gastrectomy for early gastric cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 644-647.
[7]	Damin Chen, Xiaogang Cao, Nengqi Cao. Effect of obesity on surgical treatment of gastric cancer patients [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 651-653.
[8]	Hongbin Wang, Xiao He, Jingzhou Wu. Safety and anti-reflux effect of piggyback interposition single channel jejunal reconstruction in laparoscopic proximal gastrectomy for AEG [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(05): 526-529.
[9]	Yu Song, Yang Zhao, Huijun Wang, Xinhua Liao. Relationship between preoperative BMI and postoperative complications and long-term survival in patients with resectable gastric cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(05): 530-533.
[10]	Bin Zhang, Guiqing Jia, Dongsong Wu, Lvzhou Cao, Yanling Zhang, Hao Huang, Gaoping Zhao. Analysis of 13 cases of early gastric cancer treated with functional preservation surgery [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(05): 575-579.
[11]	Yujie Xu, Guodong Zhao. Advances and challenges in the treatment of advanced gastric cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(04): 451-455.
[12]	Yong Huang, Zhi Zheng, Haiqiao Zhang, Long Wang, Chenglin Xin, Xiaoye Liu, Jie Yin, Jun Zhang. Research progress of digestive tract reconstruction after proximal gastrectomy [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(04): 456-460.
[13]	Xin Kong, Baoquan Song, Yin Liu, Jian Zhang, Huiying Qiu, Depei Wu. Intractable hiccup induced by allogeneic hematopoietic stem cell transplantation: a case report [J]. Chinese Journal of Transplantation(Electronic Edition), 2023, 17(04): 253-255.
[14]	Yingjun Tang, Huajuan Li, Saini Wang, Wang Xu, Feng Liu, Xi Li, Xinbao Hao, Huaping Huang. Effect and mechanism of human umbilical cord mesenchymal stem cells (HU-MSCs) transplantation on emphysema mice [J]. Chinese Journal of Lung Diseases(Electronic Edition), 2023, 16(04): 476-480.
[15]	Yutong Liang, Xu Ding, Guohui Ma, Yanhong Huang. Progress in treatment of intrauterine adhesions with mesenchymal stem cells [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(05): 596-599.

Please choose a citation manager

Content to export